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 Nance-Horan Syndrome (NHS; OMIM 302350) is an in-
frequent and often overlooked X-linked disorder character-
ized by dense congenital cataracts, microphthalmia, and mi-
crocornea [1-3]. Affected individuals develop dental anoma-
lies which include serrated incisal edges and barrel-shaped
teeth, in which the incisal edge and the gingival margin are
narrower than the cervix of the tooth. Distinctive facial fea-
tures include anteverted and often simplex pinnae and a long
face with a narrow mandible and a narrow nasal bridge. Some
affected males also display developmental delay [4,5]. The
phenotype of female carriers is less severe but includes cor-
neal diameters ranged midway between normal and the af-
fected males, and Y-sutural opacities which may occasionally
affect vision even at younger ages [6]. The variability among
carriers presumably results from differentially random X-in-
activation.
The gene for NHS was mapped by several investigators
to the Xp22.13 region [5,7-11]. The NHS gene was isolated
and confirmed by independent laboratories [12,13]. Two ad-
ditional studies [14,15] identified unique NHS gene mutations
in four other independent NHS families. Previously, we iden-
tified five North American families with the unifying pheno-
typic characteristics of NHS [6,16]. Here we report the analy-
ses of NHS gene mutation of these five families, bringing the
total number of unique mutations to fourteen.
METHODS
Clinical examination:  Families exhibiting X-linked congeni-
tal cataract and microcornea were ascertained through the
Medical Retina and Ocular Genetics Service of the Cullen Eye
Institute at Baylor College of Medicine in Houston and by
regional and national referral. A detailed family history and a
pedigree were obtained through personal interviews and cor-
roborated by medical and ophthalmological examination. Each
subject or the responsible adult signed a Consent for Partici-
pation which was approved by the Institutional Review Board
for Human Subject Research of the Baylor College of Medi-
cine and the corresponding committees at the Texas Children’s
Hospital and The Methodist Hospital, Houston.
Unambiguous distinctions between affected and normal
male subjects were based on clinical criteria including head
circumference, external ear length, the position of the pinnae,
the shape of the helices, hand and finger lengths, dental anoma-
lies, and ocular characteristics (Table 1). Blood samples were
obtained by a single observer with no knowledge of linkage
information. Detailed examination findings of individuals and
family pedigrees have been published elsewhere [1,6,16,17].
Mutation screening and sequence analysis:  Venous blood
from family members established permanent EBV-transformed
lymphoblastoid cultured cell lines with standard techniques
[18]. Genomic DNA was isolated from EBV transformed cells
using Qiagen kits, following the manufacturer’s recommen-
dations. Exons from the NHS gene were amplified from ge-
nomic DNA (100 ng) with primers that span intron-exon junc-
tions and primers within single large exons (primer sequences
listed in Table 2). This analysis included exon 3a which is
variably expressed in human NHS transcripts [19]. PCR was
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470performed with 0.5 U AmpliTaq gold polymerase (ABI, Fos-
ter City, CA), 10 mM Tris HCl, pH 8.3, 1.5 mM MgCl2, and
50 mu M each dATP, dTTP, dGTP, and dCTP in 50 mu l vol-
ume. Amplification was performed following these conditions:
94 °C for 5 min, followed by 35 cycles at 95 °C for 1 min, 55-
60 °C for 30 s, and 72 °C for 1 min with a final extension at 72
°C for 7 min. PCR products were separated by gel electro-
phoresis, purified over gel filtration columns (Novagen, Madi-
son, WI), and cloned into TOPO II vectors (Invitrogen,
Carlsbad, CA), or sequenced directly as necessary on a 3900
DNA Sequencer (Applied Biosystems, Foster City, CA). For
each mutation found in families XL116, XL11, and XL39, the
presence of the mutation was also analyzed in two unaffected
family members.
RESULTS & DISCUSSION
 In family XL-116, we identified a C >T nonsense mutation in
all tested affected individuals, at nucleotide 4129 of the 4893
bp human NHS cDNA. This mutation introduces a putative
premature stop codon at the end of exon 6 and would result in
a truncated protein that lacks a small part of exon 6 and all of
exons 7 and 8. Affected individuals in family XL-39 carry a C
>A nonsense mutation that introduces a putative premature
stop codon at nucleotide 3624. This mutation falls in the middle
of exon 6 and results in a truncated protein lacking part of
exon 6 and exons 7 and 8. Family XL-11 displays a C >T
nonsense mutation at nucleotide 1108. This mutation occurs
in exon 5 and predicts a truncated protein lacking part of exon
5 and all of exons 6, 7, and 8. None of these mutations was
observed in any unaffected family members. No coding re-
gion or splice site alterations were identified in families XL-
56 and XL-51. These mutation results are presented as Figure
1 and Table 3.
 Our analyses are consistent with previous reports that
showed no correlation between the NHS genotype and the se-
verity of NHS signs among affected family members [12,15].
For example, patients carrying the C >A mutation at bp 3624
present with typical NHS ocular and dental features [15]. In
contrast, patients with a TG deletion at the neighboring posi-
tions 3738-3739 have bilateral cleft palate and the classical
NHS signs [13] (family 3). Similarly, Ramprasad et al. [14]
and Burdon et al. [12] identified two different NHS mutations
within exon 1. However, the reported phenotype in patients
bearing a mutation at nucleotide 400 is more severe than those
with a mutation at nucleotide 115. A detailed structure-func-
tion analysis of the NHS protein should reconcile the pheno-
typic differences in the several NHS families.
Our study includes two families with no identified NHS
mutations in the coding region. This is consistent with previ-
ous studies [12,13] and suggests the possibility of regulatory
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TABLE 1. CLINICAL CHARACTERISTICS OF NHS PATIENTS
                                                                                                                Dysmorphic
         Congenital                                               Dental       Mental                             facial
Family    cataract    Nystagmus   Microcornea   Microphthalmia   anomalies   retardation   Brachymetacarpalia    features
------   ----------   ---------   -----------   --------------   ---------   -----------   ------------------   ----------
XL-11        +            +            +              +              +           No                +                +
XL-56        +           +/-           +              +              +           No                +                +
XL-51        +            +            +              +              +           No                +                +
XL-116       +            +            +              +              +           No                +                +
XL-39        +            +            +              +              +           No                +                +
TABLE 2. PRIMER SEQUENCES USED IN PCR OF GENOMIC DNA
471or intronic mutations in these families. Interestingly, the
equivalent mouse Xcat mutant, which is the model for human
NHS, does not display coding region mutations but does carry
a large insertion mutation within the first intron of the mouse
homolog of NHS (Nhs1) [20]. This insertion alters the expres-
sion of the Nhs1 transcript and the Nhs protein in Xcat mice.
Perhaps the NHS families who do not display NHS coding
region mutations carry alterations in intron 1 structure. It will
be interesting to explore this possibility further through the
use of cytogenetic and gene expression studies on the NHS
transformed cell lines. This study identifies additional NHS
gene mutations in NHS families and validates the model that
the NHS gene is required for proper eye development in hu-
mans. In addition, this work is consistent with the role of mouse
Nhs1 in cataract formation. Based on the phenotype of NHS
patients, the NHS gene has many specialized functions in sev-
eral different tissues. Functional studies on the NHS protein
should help illuminate its role in eye, ear, tooth, and digit de-
velopment.
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Figure 1. NHS mutation detection and localization.  A: The identification of NHS nonsense mutations in three NHS families. Chromatograms
from one affected and one unaffected individual are shown for each family. Above each tracing the base change is highlighted and the
predicted stop codon is indicated. B: The localization of the fourteen reported NHS mutations within the NHS gene: red arrow [14]; black
arrows [12]; green arrows (this study); purple arrows [15]; and blue arrows [13].
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TABLE 3. SUMMARY OF MUTATION IN THE NHS GENE
The asterisk indicates that family three from Burdon et al. [12] is unrelated to family P21450 [15] and the double asterisk indicates that family
five from Burdon et al. [12] is related to family 2 from Brooks et al. [13].
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